Steven focuses his practice on counseling medical device and in vitro diagnostic manufacturers on a broad range of pre- and post-market regulatory and compliance issues under the Food, Drug, and Cosmetic Act and related laws, including product development and marketing authorization, advertising and promotion, and inspection and enforcement matters.
Pre-market, Steven develops regulatory strategy, assists with pre-submission requests and meetings with FDA, and prepares premarket submissions, including IDEs, 510(k)s, de novos, and PMAs. He helps clients respond to FDA requests for additional information during premarket review and with administrative appeals to FDA for adverse regulatory decisions (e.g., NSE letters or de novo denials).
Post-market, Steven advises clients on issues related to complaint handling, Medical Device Reporting, field actions/recalls, promotional review, and the Quality System Regulation. He provides strategic advice and drafts company responses to FDA-483 inspection observations and warning/untitled letters.
Steven also routinely provides regulatory counsel for corporate transactions, license and collaboration agreements, manufacturing and supply arrangements, and public and private securities offerings involving drug, device, cosmetic, food, and dietary supplement companies.